Palomares M R, Sayre J W, Shekar K C, Lillington L M, Chlebowski R T
Department of Medicine, UCLA School of Medicine, Torrance, USA.
Cancer. 1996 Nov 15;78(10):2119-26. doi: 10.1002/(sici)1097-0142(19961115)78:10<2119::aid-cncr12>3.0.co;2-1.
Gender has recently emerged as a discriminating factor in nonsmall lung carcinoma (NSCLC) patient outcome. Since the potential for interaction among established prognostic factors and gender in this common disease has not been explored, the authors evaluated the role of gender and weight-loss pattern in predicting clinical outcome in a balanced population of men and women presenting with NSCLC.
From a tumor registry population of 368 NSCLC patients, a gender-balanced sample of 152 cases was randomly selected for review, using prospective inclusion criteria. Study parameters were age, race, tobacco and alcohol history, gender, weight-loss pattern, histology, TNM stage, Eastern Cooperative Oncology Group performance status, and therapy. Influences of study variables on Kaplan-Meier estimates of survival were subsequently determined using univariate and multivariate analyses.
Overall median survival after diagnosis was significantly shorter for men with NSCLC than for women with the disease (40 vs. 78 weeks, P = 0.001). Men lost significantly more weight over their disease course than women (12.2 vs. 5.4 pounds, P = 0.006) and experienced an eightfold faster rate of initial weight loss (0.25 vs. 0.03 pounds per week, P = 0.001). In multivariate analysis, the strongest independent predictors of NSCLC patient survival were stage of disease, initial weight-loss rate, and gender (all P < 0.0001).
These results suggest that weight loss may play a role in mediating gender-related differences in NSCLC patient survival and provide an impetus for further studies of gender influence on cancer outcome.
性别最近已成为非小细胞肺癌(NSCLC)患者预后的一个鉴别因素。由于尚未探讨这种常见疾病中既定预后因素与性别之间的潜在相互作用,作者评估了性别和体重减轻模式在预测患有NSCLC的男性和女性平衡人群临床结局中的作用。
从368例NSCLC患者的肿瘤登记人群中,采用前瞻性纳入标准,随机选取152例性别均衡的病例进行回顾。研究参数包括年龄、种族、吸烟和饮酒史、性别、体重减轻模式、组织学、TNM分期、东部肿瘤协作组体能状态和治疗情况。随后使用单因素和多因素分析确定研究变量对Kaplan-Meier生存估计值的影响。
NSCLC男性患者诊断后的总体中位生存期明显短于女性患者(40周对78周,P = 0.001)。男性在疾病过程中体重减轻明显多于女性(12.2磅对5.4磅,P = 0.006),且初始体重减轻速度快八倍(每周0.25磅对0.03磅,P = 0.001)。在多因素分析中,NSCLC患者生存的最强独立预测因素是疾病分期、初始体重减轻率和性别(均P < 0.0001)。
这些结果表明体重减轻可能在介导NSCLC患者生存中与性别相关的差异方面发挥作用,并为进一步研究性别对癌症结局的影响提供了动力。